Logo

VIDA

VIDA provides the new standard of pulmonary care by using AI-powered CT imaging software and services to aid the early detection, evaluation, and treatment planning of patients with or at risk of lung diseases, including emphysema and airway obstructive diseases (COPD), asthma, interstitial lung disease, and lung cancer. VIDA’s software and services are FDA cleared, CE-marked, Health Canada licensed and TGA registered for clinical use in the US, European Economic Area, Canada and Australia.

Company specifications

General
Company name VIDA
Founded 2004
Head office Coralville, United States
Website https://vidalung.ai/
Contact info@vidalung.ai

Products by this company

Logo
Subspeciality: Chest
Modality: CT

Lung disease biomarkers, lung (lobe) volume quantification, scan suitability quality check, ...

LungPrint® Discovery is an automated, AI-powered analysis of a chest CT scan, providing radiologists with visual and quantitative information relevant to COPD and ILD. It includes a patent-pending ...

CE:
Class IIa
Logo
FDA:
Class II
Logo
Information source:
Vendor
Certification verified:
Yes